Nasal swabs and lung samples from pigs experimentally infected with H 1 N 1 swine influenza virus (SIV) were examined for the presence of SIV by the indirect fluorescent antibody assay, immunohistochemistry, cell culture virus isolation, egg inoculation, and 2 human enzyme immunoassays (membrane enzyme immunoassay, microwell enzyme immunoassay). Egg inoculation was considered to be the gold standard for assay evaluation. The 2 human enzyme immunoassays (EIA) and egg inoculation agreed 100% for the prechallenge nasal swabs. Agreement on SIV identification in nasal swabs with egg inoculation following challenge was considered to be good to excellent for membrane EIA (kappa ϭ 0.85) and microwell EIA (kappa ϭ 0.86). Agreement on SIV identification in lung tissue with egg inoculation following challenge was good to excellent for membrane EIA (kappa ϭ 0.75), fair for microwell EIA, fluorescent antibody, and cell culture virus isolation (kappa ϭ 0.48, 0.64, 0.62, respectively), and poor for immunohistochemistry (kappa ϭ 0.36). No assay was 100% accurate, including the ''gold standard,'' egg inoculation. In light of this information, it is important to consider clinical signs of disease and a thorough herd history in conjunction with diagnostic results to make a diagnosis of SIV infection.
Swine influenza virus (SIV) has recently become recognized as an important pathogen of swine, incriminated along with the porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae as a cause of porcine respiratory disease complex. In 1998, tissues from over 3,000 cases of respiratory disease in swine were examined at the Veterinary Diagnostic Laboratory at Iowa State University. Evidence of SIV infection was detected in 350 cases (P. Halbur, personal communication). The number of SIV cases diagnosed in 1998 was 4 times greater than those diagnosed in 1993. Contributing to the rise in the number of SIV infections was the recognition, in late summer 1998, of the emergence of H 3 N 2 SIV. The initial case was identified in North Carolina, but by the end of the year, H 3 N 2 SIV infections had been identified in Iowa, Minnesota, and Texas. 26 Swine influenza viruses submitted to the National Veterinary Services Laboratories for serologic typing between September 1, 1998 and February 1, 2000 have been identified as approximately equal numbers of H 1 N 1 and H 3 N 2 .
The emergence of H 3 N 2 in the national swine population is not unique to the United States. The H 3 N 2 subtype has also been identified in swine populations in Canada and in countries of Europe and Asia. 1, [6] [7] [8] 15, [17] [18] [19] Additional subtypes that have been identified in the swine population include H 1 N 7 in the United Kingdom, H 1 N 2 in Europe and Asia, and avian H 1 N 1 in Europe and Asia. [2] [3] [4] [5] 13, 14, 20, 21, 23 Although these virus subtypes differ in their hemagglutinin and neuraminidase, they are all type A influenza viruses. These type A influenza viruses have a common nucleoprotein and matrix protein. Because of their common antigenic proteins, assays that use reagents directed against these antigens can be utilized to detect type A influenza viruses, regardless of the hemagglutinin or neuraminidase subtype. In addition, by substitution of some reagents in these assays, it is possible to differentiate among the types of type A influenza virus.
With the increasing demand for SIV testing comes an increasing need to utilize assays that provide accurate, rapid results, that easily allow simultaneous testing of multiple samples, and that are easy to perform and cost effective. An accurate and rapid diagnosis of SIV infection is important to implement management procedures that will reduce the severity of disease.
Virus isolation in cell culture and eggs and fluorescent antibody testing have been used for the detection of SIV in suspect materials. 11 Immunohistochemistry has recently been described as a quick method for detecting SIV in formalin-fixed tissue; this method can be used for current evaluation of samples and for retrospective studies. 24 Enzyme immunoassays for diagnosis of influenza virus have been used for humans, horses, pigs, and birds. 10, 16, 22, 25 There have been no comprehensive studies comparing egg inoculation, cell culture virus isolation, fluorescent antibody testing, immunohistochemistry, and enzyme immunoassays for detection of SIV in nasal swabs and lungs from pigs. The purpose of this study was to evaluate veterinary and human diagnostic assays for their ability to detect SIV in nasal swabs and lung tissue from pigs experimentally infected with H 1 N 1 SIV.
Materials and methods

Animals
Pigs utilized in this study were obtained from a swine herd with no clinical history of SIV infection and were SIV antibody negative (Ͻ1:10) by the hemagglutination inhibition assay at the time of placement in isolation facilities. Pigs used in this trial were part of an efficacy trial to evaluate a minimum protective pig dose of an inactivated H 1 N 1 SIV vaccine and were challenged with SIV at 8-10 wk of age. Nasal swabs were collected from 50 vaccinated and 10 nonvaccinated pigs, and lung tissue was collected from 25 vaccinated and 10 nonvaccinated pigs.
Serology
Pigs were evaluated for the presence of H 1 N 1 SIV antibodies at the beginning of the study. Sera were heat inactivated at 56 C for 30 min, and then 25 l was pretreated with 250 l of 10% rooster red blood cells to remove nonspecific inhibitors. The hemagglutination inhibition test was conducted as previously described with the following exceptions: antigen was incubated with sera for 60 min instead of 30 min and sera were not pretreated with receptor-destroying enzyme. 9
Challenge
Pigs were sedated with a combination of ketamine a (2.2 mg/kg) and xylazine b (0.55 mg/kg) given intramuscularly prior to challenge with H 1 N 1 SIV. Challenge consisted of 10 ml of SIV allantoic fluid (EID 50 Ͼ 10 7.0 /ml) given via 5-7 min of nebulization c followed by intranasal inoculation with the remaining virus.
Clinical specimens
Dacron swabs d were used to swab the nares of 73 pigs prior to challenge exposure to SIV, and 248 nasal swabs were collected from 62 of those pigs on days 2-5 postchallenge for evaluation by egg inoculation (EI) and enzyme immunoassays (EIA). Following challenge, some pigs were swabbed twice on a sample collection day, resulting in 115 nasal swabs for evaluation by immunohistochemistry (IHC). The first swab collected was placed in modified Eagle medium c containing gentamicin sulfate f and amphotericin B. g Excess medium was expressed from the swab and used to swab the nares. The swab was then placed in 1.5 ml of medium and stored at Ϫ70 C until evaluated by EI and EIA. The second swab was used to prepare a microscope slide smear for IHC evaluation.
Lung samples were randomly collected from 35 pigs on day 5 postchallenge. A portion of lung from each pig was held at 4 C for cell culture virus isolation (VI) and fluorescent antibody (FA) testing, at Ϫ70 C for EI and EIA, and in 10% formalin for IHC.
Specimen preparation
Nasal swab slides for IHC were fixed in acetone for 30 sec and air dried. Frozen nasal swabs were thawed at 37 C, excess fluid was expressed into the tube, and the swabs were discarded. The medium was used without centrifugation for the EIA. The swab medium was then centrifuged at 2,000 ϫ g for 10 min at 4 C, and the supernatant was collected for EI. Lung samples for EI were thawed at 37 C, and a 10% homogenate was prepared using modified Eagle medium supplemented with gentamicin sulfate and amphotericin B. The homogenate was centrifuged at 2,000 ϫ g for 10 min at 4 C, and the supernatant was collected for EI. Lungs for FA were prepared as previously described. 2 Formalinfixed lungs for IHC were processed to paraffin blocks and mounted on poly-L-lysine-coated glass slides. h A 20-30% suspension of lung tissue was prepared in minimum essential medium g supplemented with balanced salts, g penicillin G, i streptomycin, i gentamicin sulfate, and amphotericin B. Samples were centrifuged at 1,900 ϫ g for 20-30 min and 4 C, and the supernatant was collected for virus isolation.
Statistics
The level of agreement between the ''gold standard'' of EI and the other diagnostic tests was determined using the kappa statistic. 12 A diagnostic test was determined to have good to excellent agreement if the kappa value was 0.75-1.00, fair agreement if the kappa value was 0.40-0.74, and poor agreement if the kappa value was Ͻ0.40.
Assays
The initial test result for each assay was considered to be the true SIV status of the sample except for results that were inconclusive. In those cases, samples were retested and the second result was used as the true SIV status of the sample. In instances where there were discrepancies between EI and EIA results samples were retested to determine if their status was incorrectly identified on initial testing. Personnel evaluating the results of an assay were not aware of results from the other assays and were not aware of the vaccination status of the pigs from which the samples were collected.
Egg inoculation. Eleven-day-old specific-pathogen-free embryonated eggs i were used for evaluation of nasal swabs and lungs. Lung supernatant was diluted 1:10, and nasal swab supernatant was diluted 1:10 and 1:100 in modified Eagle medium containing gentamicin sulfate and amphotericin B. Two eggs/dilution were inoculated with 0.2 ml of inoculum in the allantoic cavity. Two eggs were also inoculated with undiluted lung supernatant. Eggs were candled at 24 hr postinoculation, and dead eggs were discarded. If 3 or more eggs were dead at the end of the 72-hr incubation period, 2 additional eggs for each dilution of the sample were inoculated. Allantoic fluid was harvested from each egg at 72 hr postinoculation and was assayed for SIV. Allantoic fluids from each egg for an individual pig were not pooled to prevent dilutional affects that could result in a (6) 1.6 (4) 2.8 (7) 6.9 (17) 6.5 (16) * EIA ϭ enzyme immunoassay. † Although 248 samples were evaluated results for 1 sample were inconclusive on initial test and retest. false-negative result. The presence of SIV was determined using a hemagglutination assay. Equal volumes of allantoic fluid and 0.5% chicken red blood cells were mixed together in v-bottom microtiter plates. k The test was read for the presence of hemagglutination after a 40-minute incubation at room temperature. The nasal swabs and lungs were considered positive if Ն1 egg was positive for virus. Enzyme immunoassays. Microwell l and membrane m enzyme immunoassays were used to evaluate the presence of SIV in nasal swabs and lungs. Both assays were performed according to the manufacturers' instructions. Samples testing in the indeterminant range on the microwell immunoassay were retested without further processing. Samples with inconclusive test results on the membrane immunoassay were retested after diluting 1:4 in saline.
Immunohistochemistry. Nasal swab slides and lung tissue sections were processed as previously described for lung tissue except that lung tissue was held in formalin for Ͼ24 hr prior to processing into paraffin blocks. 24 Cell culture virus isolation. Tissue supernatant was adsorbed to confluent (48-72 hr postseeding) primary fetal porcine kidney cells for 1-2 hr at 37 C. The inoculum was removed, the cells were washed with medium 3 times, and fresh medium containing 2.5% irradiated serum was added to the flask and incubated at 37 C. Cells were evaluated every other day for cytopathic effects (CPE). After 7 days, the cells were frozen at Ϫ70 C, thawed, and subpassaged onto fresh primary fetal porcine kidney cells on glass slides in Leighton tubes. n All cultures exhibiting CPE and all cultures after 5-7 days of subpassage incubation were stained with a polyclonal anti-swine influenza FA conjugate and evaluated for the presence of SIV.
Fluorescent antibody assay. Lung tissue for direct FA was processed as previously described using a polyclonal antibody for detection of SIV. 2
Results
Nasal swabs. Both EIA and EI were in complete agreement on the prechallenge nasal swabs, with 73/ 73 negative samples. Of the 248 nasal swabs collected postchallenge, 64.5% of the samples were positive for SIV by EI. Postchallenge nasal swab agreement with EI was considered to be good to excellent based on kappa values of 0.85 for the membrane EIA and 0.86 for the microwell EIA (Table 1) . Reported results are the initial test results in instances where samples were tested more than once by an assay. For the membrane EIA, microwell EIA, IHC, and EI assays, 0.8%, 2.4%, 23.5%, and 0% of nasal swabs respectively, produced inconclusive initial test results. Because of the large number of IHC slides with inconclusive results due to loss of cells and considering that the swab used for IHC was not the same swab as that used for EIA and EI, kappa analysis was not done for nasal swab IHC comparison, and results are not reported. When samples with inconclusive initial test results were retested, results were obtained for all samples with the membrane EIA and for all but 1 sample with the microwell EIA. Discordant samples were retested by EIA and EI ( Table 2 ). Three nasal swabs were positive by both the membrane EIA and microwell EIA and were negative by EI. Upon retesting in eggs, 2 nasal swabs were identified as positive. One of 2 nasal swabs initially identified as negative by EI, positive by membrane EIA, and negative by microwell EIA was positive on retest in eggs. Four of 4 nasal swabs initially identified as negative by EI, positive by microwell EIA, and negative by membrane EIA remained negative on retest in eggs. The 4 samples were negative by microwell EIA on retest.
When the nasal swab results for each assay were compared for vaccinates and nonvaccinates, it was apparent that the assays differed in their ability to detect virus in vaccinated pigs. Virus detection in swabs of vaccinated pigs was comparable on days 2 and 3 following challenge for both EIA and EI (data not shown). Beginning on day 4 and continuing through day 5 following challenge, the EIA detected virus from fewer vaccinated pigs than did EI. On day 5, the number of vaccinated pigs with positive SIV nasal swabs by EI was 18 compared with 9 for the microwell EIA and 10 for the membrane EIA.
Lungs. Of the 35 lung samples evaluated following challenge, 37.8% were positive for SIV by EI. Postchallenge lung agreement with EI ( Table 3 ) was good to excellent for membrane EIA (kappa ϭ 0.75), fair for microwell EIA, FA, and VI (kappa ϭ 0.48, 0.64, 0.62, respectively), and poor for IHC (kappa ϭ 0.36). For the membrane EIA and microwell EIA, 18.9% and 11.8% of lung samples, respectively, produced inconclusive initial test results. Upon retesting, results were obtained for all samples with the membrane EIA and for all but 2 samples with the microwell EIA. Discordant egg and EIA samples were retested by EI and EIA (Table 4 ). One EI-negative sample was positive by all other assays and was also positive upon retesting in eggs. In Table 3 , the egg-/assayϩ results for membrane EIA and for VI would change to 0 because of this single sample.
Discussion
The purpose of this study was to examine the ability of veterinary and human diagnostic assays to detect the presence of H 1 N 1 SIV in lung and nasal swab specimens from experimentally infected pigs. These are the same types of specimens likely to be submitted to a diagnostic facility for detection of field virus. Compared with EI, the 2 EIA, performed very well for identification of SIV in nasal swabs. With lung samples, agreement with EI ranged from poor for IHC, to fair for microwell EIA, FA, and VI, to good to excellent for membrane EIA.
Much of the focus of this study was on comparing EI with the EIA because EIA can be used to obtain rapid results and to test multiple samples. Egg inoculation was considered the gold standard for comparison because it has been used extensively by the authors for SIV identification in experimentally infected pigs. Samples collected for this study were from pigs that were experimentally infected; consequently, sample handling was performed in a manner to ensure maintenance of live virus for EI.
Vaccinated challenged pigs were used instead of nonvaccinated challenged pigs to evaluate the presence of SIV in nasal swabs and lungs. Use of vaccinated pigs in this study is justified because Ͼ21 million doses of H 1 N 1 SIV vaccine have been sold in the USA, and vaccinated swine represent the swine population and, therefore, the type of swine samples submitted to a diagnostic laboratory.
The IHC test did not perform well for nasal swabs in this study. Two factors may have influenced the results of this assay. First, preparation and fixing of swab slides were not optimized as evidenced by the number of samples that were inconclusive due to loss of cells during processing. Second, swabs used to prepare the slides were collected after the swabs were collected for EI and EIA. Sufficient cells infected with SIV may not have been present in the nares following the first swabbing to allow for detection by IHC. Additional work is needed to optimize this test method, which could be a rapid method for antemortem diagnosis of SIV infections.
Although the viral status of several nasal swab samples was incorrectly identified, the performance of the 2 EIAs of postchallenge nasal swabs was considered good to excellent compared with EI. Several factors may be responsible for the difference between the EIA and EI results. The freeze-thaw process may have influenced virus detection. The instructions supplied with the microwell assay indicate that previous work has shown reduced sensitivity of the assay when samples have been frozen, which may explain why initial assay results on 7 nasal swabs were positive by EIA and negative at a later date, when the samples had been centrifuged and had undergone a second freeze-thaw process. Nasal mucus may have influenced the assays by plugging the assay membrane or the sample dispenser filter of the membrane EIA or by coating the wells in the microwell EIA.
The number of virus particles in nasal swabs may have been too low to be detected by the EIA but may have been high enough to be detected by EI because of viral replication in the eggs during the 72-hour incubation period. This situation may also pertain to the differences in virus detection between vaccinates and nonvaccinates. Vaccinated pigs would be more likely to shed fewer virus particles and for shorter periods of time than would nonvaccinated pigs. In this study, on day 4 and continuing through day 5 following challenge the EIA detected virus from fewer vaccinated pigs than did EI. On day 5, the number of vaccinated pigs with positive SIV nasal swabs by EI was 18 compared with 9 for the microwell EIA and 10 for the membrane EIA.
The low number of positive results from lungs is not considered unusual. Swine influenza virus infections alone are usually of short duration. In addition, the majority of the pigs evaluated were previously vaccinated with an inactivated SIV vaccine, and less virus would be expected in vaccinates than in nonvaccinated controls. A limited number of lung samples were evaluated by the 6 assays examined in this study because of funding contraints and the expectation that virus would be identified in relatively few lung samples from vaccinated pigs on day 5 postchallenge. As a result, a single misidentified sample was capable of shifting the agreement by almost 3%.
A number of factors may have been responsible for the different levels of agreement between EI and the other assays. The use of different lung samples from the same pig for performing the assays may have influenced the outcome of the assays and contributed to discordant results due to localization of SIV in the lung. Egg inoculation and both EIAs were performed at the same laboratory using the same lung homogenate. The FA and IHC were performed at a second laboratory, and the VI performed at a third laboratory.
The IHC has previously been shown to have sensitivity equal to VI and superior to FA. 24 In this study, IHC did not perform as well as VI and FA. The formalin-fixed lungs were processed into paraffin blocks several days after collection instead of within 24-48 hours of placing in formalin. The samples may have been adversely affected by prolonged storage in formalin, as suggested by the high percentage of eggpositive/IHC-negative samples. Adverse effects of formalin on IHC results have been observed with mycoplasmas (P. Halbur, personal communication). The EIA may have been influenced by cell debris and red blood cell contamination of the lung homogenate, resulting in large numbers of inconclusive test results. In the membrane EIA, the membrane became discolored, making interpretation of the results difficult. The high rate of inconclusive test results and the expense of these tests compared with other tests would prohibit the use of the EIA for routine testing if alternative methods of handling lung samples were not employed. For example, lung swabs may have been better for evaluating SIV in the lower respiratory tract (J. Collins, personal communication). Crude mincing of the tissue in an appropriate diluent may have been better than homogenizing the tissue (G. Erickson, personal communication).
When discordant samples were retested by EI, it was discovered that some positive samples were not detected by EI initially. Nine of 248 postchallenge nasal swabs were positive by 1 (6 samples) or both (3 samples) EIA and negative by EI on initial test. When the 9 samples were retested in eggs, 3 contained virus. Four of the samples positive only on the microwell EIA were retested by the microwell EIA and EI. On both tests, the 4 samples were negative. Although the freeze-thaw cycle the samples went through before retesting could have adversely affected the microwell EIA retest results, the 4 samples were clustered in the last column on the plate, suggesting the potential for false-positive results. One of 35 lung samples was positive on more than 1 assay and negative by EI on initial test. When that sample was retested in eggs, it contained SIV. Samples were evaluated through 1 passage in eggs in this study. Had the samples been passed more than once in eggs, fewer samples may have been misidentified as negative.
When evaluating methods of identification of SIV and determining what assay(s) to utilize, it is important to consider a number of factors, including type of sample submitted, ability to assay multiple samples at a time, ability to obtain results the same day the sample is submitted, equipment needs, technical expertise necessary to perform or read the test, cost to perform the assay, retest rate due to inconclusive results, and accuracy of the results. Regardless of the assay(s) utilized for diagnosis of SIV infection, sample selection is a critical factor in making an accurate diagnosis. If the sample is not collected correctly, not collected at the correct time of infection, or handled improperly after collection, test results may not accurately reflect the disease status of the pig. Samples should be collected from an acutely affected pig that is febrile, demonstrates a sharp, hacking cough (''barking''), and has not been medically treated. Lung samples should be collected by sterile technique and, if possible, obtained from a euthanized pig. Nasal swabs should be collected from pigs after the nose has been cleaned to remove organic debris. The swab should be passed deep into the nasal cavity of both nostrils. Blood and mucopurulent nasal discharge can adversely affect identification of SIV with VI, EI, and EIA. Samples should be kept cool and shipped overnight to the diagnostic laboratory to reduce bacterial contamination and viral degradation. Formalin-fixed tissues should be transferred into paraffin blocks as soon as tissues are properly fixed to reduce the potential for adverse affects of formalin on the IHC assay.
Samples collected during the course of this study were obtained from pigs experimentally infected with H 1 N 1 SIV at times when viral shedding from the nose and virus localization in the lung were known to occur. Sample collection and handling was optimized to ensure survival of SIV if it was initially present in the collected sample. As demonstrated in this study, even when conditions were optimized for identification of SIV, no assay was 100% accurate, including the gold standard of EI. Diagnostic results need to be interpreted in conjunction with clinical signs of disease and a thorough herd history to make a diagnosis of SIV infection.
